Back to Search
LILIAN MULDOON, MD, MPH
MD, MPH
Emergency Medicine Physician
NPI: 1407233315IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
A147298(CA)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
PMID 17538176·J Clin Oncol·2007
6-review
Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat.
PMID 14720178·Neuropathol Appl Neurobiol·2004
4-observational
Effect of antigenic heterogeneity on the efficacy of enhanced delivery of antibody-targeted chemotherapy in a human lung cancer intracerebral xenograft model in rats.
PMID 14633307·Neurosurgery·2003
7-preclinical
Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.
PMID 19142191·J Cereb Blood Flow Metab·2009
4-observational
Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.
PMID 19177203·Neoplasia·2009
7-preclinical
Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.
PMID 18772353·Neuro Oncol·2009
7-preclinical
Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.
PMID 19158414·Neuro Oncol·2009
7-preclinical
siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli.
PMID 19081762·Cancer Ther·2008
8-other
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.
PMID 17909806·Cancer Chemother Pharmacol·2008
7-preclinical
Framework for primary care organizations: the importance of a structural domain.
PMID 18055502·Int J Qual Health Care·2008
8-other
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
PMID 18072268·Cancer·2008
3-trial
N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
PMID 18295688·J Vasc Interv Radiol·2008
6-review
Characterization and magnetic resonance imaging of a rat model of human B-cell central nervous system lymphoma.
PMID 17438111·Clin Cancer Res·2007
7-preclinical
In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging.
PMID 17898131·Am J Physiol Cell Physiol·2007
4-observational
Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting.
PMID 16858513·J Neurooncol·2007
7-preclinical
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
PMID 16314949·J Neurooncol·2006
4-observational
Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.
PMID 16552023·AJNR Am J Neuroradiol·2006
8-other
Implications of the blood-brain barrier in primary central nervous system lymphoma.
PMID 17134113·Neurosurg Focus·2006
6-review
Models of primary care service delivery in Ontario: why such diversity?
PMID 17722757·Healthc Manage Forum·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 505 PARNASSUS AVE, ROOM M-24 BOX 0203
SAN FRANCISCO, CA 94143 - Phone
- (303) 887-3304
Quick Facts
- NPI
- 1407233315
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile